O

    OPTIMIZERx Corp (OPRX)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $7.98
    +0.03 (+0.38%)

    Market Cap: $149.75M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    72%(26/36)
    Avg Surprise
    +63.95%
    Streak
    1 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.17
    Range$0.10 - $0.22
    4 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$0.24+41.2%
    60d ago$0.25+44.7%
    30d ago$0.25+44.7%
    7d ago$0.25+44.7%
    Current$0.17
    Revenue Consensus
    $22M
    Range$21M - $24M
    6 analysts
    Dec 31, 2026
    EPS Consensus$0.60
    Range$0.43 - $0.70
    4 analysts
    Revenue Consensus
    $36M
    Range$35M - $38M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.60---
    Sep 26EST
    		-$0.17---
    Jun 26
    		$0.08$0.01+700.00%Beat-50.0%
    Mar 26
    		$0.00N/A-100.00%Miss-100.0%
    Dec 25
    		$0.51$0.22+131.82%Beat+264.3%
    Sep 25
    		$0.20$0.04+400.00%Beat+66.7%
    Jun 25
    		$0.16$-0.09+277.78%Beat+700.0%
    Mar 25
    		$0.08$-0.12+166.67%Beat+172.7%
    Dec 24
    		$0.14$0.10+40.00%Beat-46.2%
    Sep 24
    		$0.12$0.06+100.00%Beat+33.3%
    Jun 24
    		$0.02N/A+128.57%Beat+300.0%
    Mar 24
    		$-0.11$-0.10-10.00%Miss-22.2%
    Dec 23
    		$0.26$0.32-18.75%Miss+4.0%
    Sep 23
    		$0.09$0.04+125.00%Beat+28.6%
    Jun 23
    		$-0.01$-0.02+50.00%Beat-125.0%
    Mar 23
    		$-0.09$-0.08-12.50%Miss-800.0%
    Dec 22
    		$0.25$0.24+4.17%Beat+13.6%
    Sep 22
    		$0.07$0.04+75.00%Beat-22.2%
    Jun 22
    		$0.04N/A-55.56%Miss-60.0%
    Mar 22
    		$-0.01$-0.01+0.00%Beat-133.3%
    Dec 21
    		$0.22$0.21+4.76%Beat+37.5%
    Sep 21
    		$0.09$0.13-30.77%Miss+50.0%
    Jun 21
    		$0.10$0.07+42.86%Beat+400.0%
    Mar 21
    		$0.03$0.01+200.00%Beat+150.0%
    Dec 20
    		$0.16$0.16+0.00%Beat+633.3%
    Sep 20
    		$0.06$0.04+50.00%Beat+220.0%
    Jun 20
    		$0.02$-0.03+166.67%Beat-77.8%
    Mar 20
    		$-0.06$-0.03-100.00%Miss-200.0%
    Dec 19
    		$-0.03$0.01-400.00%Miss-200.0%
    Sep 19
    		$-0.05$0.08-162.50%Miss-171.4%
    Jun 19
    		$0.09$0.08+12.50%Beat+28.6%
    Mar 19
    		$0.06$0.02+200.00%Beat+100.0%
    Dec 18
    		$-0.01$-0.01+0.00%Beat+66.7%
    Sep 18
    		$0.07$0.06+16.67%Beat+275.0%
    Jun 18
    		$0.07$0.03+133.33%Beat+275.0%
    Mar 18
    		$0.03$-0.03+200.00%Beat+200.0%
    Dec 17
    		$-0.03$-0.03+0.00%Beat-50.0%
    Sep 17
    		$-0.04$-0.03-33.33%Miss-100.0%
    Jun 17
    		$-0.04N/AN/ABeat-
    Mar 17
    		$-0.03N/AN/ABeat-
    Dec 16
    		$-0.02$0.00N/ABeat-
    Sep 16
    		$-0.02$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio8.40EV/EBITDA9.16x
    Price/FCF8.25xFCF Yield12.12%
    Profitability
    Profit Margin4.66%Operating Margin-0.43%
    ROE3.68%ROIC5.03%
    Financial Health
    Debt/Equity0.15xInterest Coverage2.38x
    Current Ratio5.58xQuick Ratio5.58x
    Trading Statistics
    Beta1.05Avg Volume245.24K
    52-Week High$22.2552-Week Low$4.54

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.89
    SMA 20$7.67
    SMA 50$6.71
    SMA 200$8.49
    EMA 10$7.85
    EMA 20$7.61
    EMA 50$7.00
    EMA 200$8.21

    MACD

    Line: 0.36Signal: 0.41Hist: -0.05

    ADX

    ADX: 28.0+DI: 25.0-DI: 12.7

    Aroon & PSAR

    Aroon Up56.0
    Aroon Down16.0
    PSAR$8.83

    Bollinger Bands

    Upper Band$8.95
    Lower Band$6.39
    %B Position3342%(Upper)
    Band Width0.62

    RSI (14-Day)

    Neutral
    61.2

    Momentum Oscillators

    Stoch %K53.8
    Stoch %D51.4
    Williams %R-43.8
    ROC (10d)-5.9%
    Momentum-0.50
    CCI (20d)30.8
    MFI (14d)62.7

    Volatility Measures

    ATR (14d)$0.47(5.9%)
    StdDev (20d)0.64
    Hist Vol96.4%(High)

    Volume Flow

    VWAP$7.90
    OBV20.9M
    AD Line6.3M
    CMF (20d)0.133

    Volume Metrics

    Avg Vol (20d)252.1K
    Vol Ratio0.7x
    VWMA (20d)$7.90

    Pivot Points

    R3$8.65
    R2$8.37
    R1$8.16
    Pivot Point$7.88
    S1$7.67
    S2$7.39
    S3$7.18

    Advanced Oscillators

    TSI24.02
    Ultimate Osc49.9
    KST223.83

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$20.50M$19.84M$32.24M$26.07M$29.20M$21.93M$32.32M$21.31M$18.81M$19.69M$28.37M$16.33M
    Cost of Revenue$4.82M$4.91M$8.14M$8.55M$10.56M$8.58M$10.29M$7.86M$7.11M$7.49M$10.53M$6.53M
    Gross Profit$15.69M$14.93M$24.10M$17.52M$18.64M$13.34M$22.02M$13.45M$11.70M$12.20M$17.84M$9.80M
    Operating Expenses$15.78M$14.54M$15.53M$15.47M$15.43M$15.45M$18.39M$22.01M$15.45M$17.23M$26.64M$13.35M
    R&D$3.27M$3.40M$0$0$3.09M$3.25M$0$0$0$0$0$0
    SG&A$3.70M$3.51M$7.12M$14.39M$3.91M$4.56M$5.83M$13.43M$14.38M$16.17M$5.18M$12.89M
    Operating Income$-88,000$396,000$8.57M$2.05M$3.21M$-2,102,000$3.63M$-8,562,000$-3,749,000$-5,029,000$-10,937,000$-3,553,000
    Interest Income$81,000$77,000$84,000$91,000$90,000$88,000$96,000$107,000$106,000$20,000$118,000$688,000
    Interest Expense$1.13M$1.16M$1.24M$1.15M$1.60M$1.30M$1.56M$1.52M$1.53M$1.55M$836,000$0
    Income Before Tax$-1,096,000$-644,000$7.47M$1.05M$1.73M$-3,272,000$2.21M$-9,941,000$-5,096,000$-6,555,000$-11,773,000$-2,865,000
    Income Tax Expense$-393,000$-149,000$2.45M$270,000$199,000$-1,073,000$2.29M$-817,000$-1,088,000$344,000$-7,631,000$0
    Net Income$-703,000$-495,000$5.02M$779,000$1.53M$-2,199,000$-79,000$-9,124,000$-4,008,000$-6,899,000$-4,142,000$-2,865,000
    EBITDA$1.29M$1.86M$10.03M$3.37M$4.75M$-795,000$5.05M$-7,247,000$-2,418,000$-3,780,000$-9,719,000$-3,087,000
    EBIT$-50,000$434,000$8.63M$2.11M$3.24M$-2,063,000$3.67M$-8,524,000$-3,674,000$-5,029,000$-10,937,000$-3,553,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OPRX

    News

    OptimizeRx (NASDAQ: OPRX) insider logs new stock trade

    OptimizeRx Chief Business Officer Andrew J. D'Silva reported an acquisition of 57,600 shares of common stock through a restricted stock unit grant. The shares, valued at $0.00 each, will vest in three equal annual installments starting August 20, 2027. Following this transaction, D'Silva directly holds 101,092 shares of OptimizeRx common stock.

    Stock Titan•8/24/26•
    Neutral

    OptimizeRx (NASDAQ: OPRX) COO keeps 25,187 shares after RSU tax withholding

    OptimizeRx Corp (OPRX) Chief Operating Officer Brendan W. Merrell reported an insider transaction where 1,020 shares of common stock were withheld for tax obligations upon the vesting of restricted stock units on August 21, 2026, at $7.71 per share. This withholding is considered a disposition under Section 16, and Merrell now directly holds 25,187 shares. The transaction has a neutral impact and sentiment according to the filing summary.

    Stock Titan•8/24/26•
    Neutral

    Citizens raises OptimizeRx stock price target on macro stability

    Citizens has increased its price target for OptimizeRx (NASDAQ: OPRX) shares to $11.00 from $9.00, maintaining a Market Outperform rating. The upward revision is attributed to a more stable macroeconomic environment and the anticipated return of a major customer in late 2026 or 2027, alongside continued momentum in mid-tier biopharmas. The new target reflects an 8x 2026 EBITDA multiple, up from 7x, based on improved conviction in future financial estimates and the company's strategic initiatives.

    Investing.com•8/14/26•
    Bullish

    OptimizeRx Corp (OPRX) gains 6.7% institutional holder in Kennedy Capital

    Kennedy Capital Management LLC has reported a beneficial ownership of 1,248,899 shares of OptimizeRx Corp (OPRX) common stock, representing a 6.7% stake. The firm, based in St. Louis, Missouri, holds sole voting and dispositive power over these shares, establishing itself as a significant institutional investor in OptimizeRx. This disclosure was made through a Schedule 13G filing, indicating a passive investment.

    Stock Titan•8/14/26•
    Somewhat-Bullish

    Renaissance Technologies LLC Has $1.36 Million Stock Position in OptimizeRx Corp. $OPRX

    Renaissance Technologies LLC significantly increased its stake in OptimizeRx Corp. (NASDAQ:OPRX) by 633.2% in the first quarter, now holding 216,856 shares valued at $1.36 million. OptimizeRx reported strong Q2 earnings, beating analyst estimates with $0.16 EPS and $20.5 million in revenue, and maintained its 2026 revenue guidance. Despite some revenue headwinds and a CFO transition, analysts have a "Moderate Buy" rating with an average price target of $13.14.

    MarketBeat•8/14/26•
    Somewhat-Bullish

    Frequently Asked Questions About OPRX

    Does OPRX pay dividends?
    OPTIMIZERx Corp (OPRX) does not currently pay a regular dividend.
    What is OPRX's P/E ratio?
    OPTIMIZERx Corp has a price-to-earnings (P/E) ratio of 8.40.
    What is OPRX's market cap?
    OPTIMIZERx Corp (OPRX) has a market capitalization of $149.75M with a current stock price of $7.98.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In